← Back to guidelines
Cardiology23 papers

Telangiectasis of vocal fold

Last edited: 4/22/2026

Overview

Juxtafoveal telangiectasis (JFT) involves abnormal dilation of retinal vessels near the fovea, potentially leading to macular edema, neovascularization, and visual impairment. This condition can be idiopathic or associated with radiation exposure 3.

Diagnosis

  • Fluorescein angiography (FA): Essential for identifying telangiectatic vessels and associated neovascularization 25.
  • Optical coherence tomography (OCT): Useful for detecting macular edema, foveal cysts, intraretinal hyperreflective lesions, and foveal flattening, particularly in JFT type II 1.
  • Retinal imaging: Helps in grading severity and monitoring progression 14.
  • Management

  • Photodynamic therapy (PDT) with verteporfin: Effective for treating subfoveal neovascularization, often combined with intravitreal triamcinolone acetonide 2.
  • Intravitreal triamcinolone acetonide: Used adjunctively to PDT for reducing macular edema and enhancing visual outcomes 2.
  • Grid laser photocoagulation: Not recommended for improving visual acuity in bilateral juxtafoveal telangiectasis; may lead to complications like retinal vascular distortion and hemorrhages 4.
  • Special Populations

  • Radiation exposure: History of head or neck irradiation significantly increases risk of idiopathic perifoveal telangiectasis 3.
  • Key Recommendations

  • Utilize fluorescein angiography for diagnosis and monitoring of juxtafoveal telangiectasis 25. (Evidence: Moderate)
  • Consider photodynamic therapy combined with intravitreal triamcinolone acetonide for subfoveal neovascularization 2. (Evidence: Moderate)
  • Avoid grid laser photocoagulation for macular edema in bilateral juxtafoveal telangiectasis due to lack of visual benefit and potential complications 4. (Evidence: Moderate)
  • Evaluate patients for history of radiation exposure, especially head or neck irradiation, as a risk factor for idiopathic perifoveal telangiectasis 3. (Evidence: Moderate)
  • References

    1 Surguch V, Gamulescu MA, Gabel VP. Optical coherence tomography findings in idiopathic juxtafoveal retinal telangiectasis. Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie 2007. link 2 Smithen LM, Spaide RF. Photodynamic therapy and intravitreal triamcinolone for a subretinal neovascularization in bilateral idiopathic juxtafoveal telangiectasis. American journal of ophthalmology 2004. link 3 Maberley DA, Yannuzzi LA, Gitter K, Singerman L, Chew E, Freund KB et al.. Radiation exposure: a new risk factor for idiopathic perifoveal telangiectasis. Ophthalmology 1999. link90523-7) 4 Park DW, Schatz H, McDonald HR, Johnson RN. Grid laser photocoagulation for macular edema in bilateral juxtafoveal telangiectasis. Ophthalmology 1997. link30019-0) 5 Chopdar A. Retinal telangiectasis in adults: fluorescein angiographic findings and treatment by argon laser. The British journal of ophthalmology 1978. link

    Original source

    1. [1]
      Optical coherence tomography findings in idiopathic juxtafoveal retinal telangiectasis.Surguch V, Gamulescu MA, Gabel VP Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie (2007)
    2. [2]
    3. [3]
      Radiation exposure: a new risk factor for idiopathic perifoveal telangiectasis.Maberley DA, Yannuzzi LA, Gitter K, Singerman L, Chew E, Freund KB et al. Ophthalmology (1999)
    4. [4]
      Grid laser photocoagulation for macular edema in bilateral juxtafoveal telangiectasis.Park DW, Schatz H, McDonald HR, Johnson RN Ophthalmology (1997)
    5. [5]

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG